| Recruiting | Rivaroxaban in Idiopathic Membranous Nephropathy NCT07404436 | Beijing Friendship Hospital | Phase 4 |
| Unknown | the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephro NCT06245707 | Beijing Friendship Hospital | N/A |
| Unknown | Obinutuzumab in the Management of Idiopathic Membranous Nephropathy NCT05845762 | Qianfoshan Hospital | — |
| Unknown | Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMN NCT05850845 | Qianfoshan Hospital | — |
| Unknown | Prognostic Model of GC/TAC in the Treatment of MN NCT05667896 | Qianfoshan Hospital | — |
| Unknown | Prognostic Model of Rituximab in the Treatment of MN NCT05667909 | Qianfoshan Hospital | — |
| Unknown | Prognostic Model of TAC in the Treatment of MN NCT05667922 | Qianfoshan Hospital | — |
| Unknown | Prognostic Model of GC/CTX in the Treatment of MN NCT05667883 | Qianfoshan Hospital | — |
| Recruiting | Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy NCT05839314 | Chinese PLA General Hospital | Phase 4 |
| Unknown | Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC NCT05797038 | Qianfoshan Hospital | — |
| Unknown | COVID-19 Infection and Idiopathic Membranous Nephropathy NCT05691179 | Beijing Friendship Hospital | — |
| Unknown | Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy NCT05782933 | Beijing Friendship Hospital | N/A |
| Terminated | Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN NCT04743739 | Peking Union Medical College Hospital | Phase 3 |
| Recruiting | Different Immunosuppressive Treatment in iMN NCT04745728 | Peking Union Medical College Hospital | Phase 3 |
| Unknown | The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idi NCT04498962 | Jingqing Hu | N/A |
| Completed | Personalized Medicine for Membranous Nephropathy NCT03804359 | Centre Hospitalier Universitaire de Nice | Phase 2 |
| Terminated | Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy NCT04154787 | Novartis Pharmaceuticals | Phase 2 |
| Unknown | Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy NCT03864250 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Unknown | Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN) NCT03549663 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Unknown | Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephrop NCT03170323 | Guangdong Provincial People's Hospital | Phase 4 |
| Terminated | The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stag NCT03466801 | Wenhu Liu | N/A |
| Terminated | Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropa NCT03475602 | Guangdong Provincial People's Hospital | — |
| Unknown | Study on the Therapeutic Effect of TCM Treatment for MDR MN NCT02610595 | Shanghai University of Traditional Chinese Medicine | N/A |
| Unknown | A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy NCT02173106 | Sun Yat-sen University | Phase 2 |
| Completed | Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy NCT01508468 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | MEmbranous Nephropathy Trial Of Rituximab NCT01180036 | Mayo Clinic | Phase 2 / Phase 3 |
| Completed | Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy NCT01845688 | wanglin | N/A |
| Completed | Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients NCT01386554 | Mallinckrodt | Phase 4 |
| Unknown | Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy NCT01799460 | Shanghai University of Traditional Chinese Medicine | — |
| Withdrawn | Aliskiren in Patients With Idiopathic Membranous Nephropathy NCT01093781 | Mayo Clinic | N/A |
| Completed | Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Ste NCT01161459 | Zhi-Hong Liu, M.D. | N/A |
| Completed | Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy NCT00805753 | Mayo Clinic | Phase 1 |
| Completed | Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy NCT00694863 | Radboud University Medical Center | Phase 2 |
| Completed | Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy NCT00302523 | Nanjing University School of Medicine | N/A |
| Completed | Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome NCT00362531 | Peking University | Phase 2 / Phase 3 |